Yasmine Amitay - Concepedia

Author

Yasmine Amitay

Shaare Zedek Medical Center

Also Known As

Y. Amitay, Yasmine Amitay

Publications

758

Citations

H-Index

Concepts

All Affiliations

Shaare Zedek Medical Center Hebrew University of Jerusalem Sheba Medical Center

About

Yasmine Amitay is an author at Shaare Zedek Medical Center specializing in pharmacology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	529
2	Biochemistry	4	4	173
3	Natural Sciences	3	3	101
4	Health Sciences	2	2	160
5	Biomolecular Engineering	2	2	86

Yasmine Amitay

Publications

710

Citations

H-Index

Page 1

	Year	Citations
Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models Alberto Gabizón, Dina Tzemach, Jenny Gorin, Cancer Chemotherapy and Pharmacology Drug TargetingMedicinePharmacologyTherapeutic ActivityFolate-targeted Liposomal Doxorubicin	2009	116
Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells Hilary Shmeeda, Yasmine Amitay, Jenny Gorin, Journal of Controlled Release Cell-based Drug DeliveryNanomedicineZoledronic AcidDrug TargetingPolymer-drug Conjugate	2010	94
Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity Yogita P. Patil, Yasmine Amitay, Patricia Ohana, Journal of Controlled Release Folate ReceptorDrug TargetingMedicineLiposomal Mitomycin-c ProdrugTumor Targeting	2016	85
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity Hilary Shmeeda, Yasmine Amitay, Dina Tzemach, Journal of Controlled Release Lipid PreparationNanomedicineZoledronic Acid ResultsBiochemistryMedicine	2013	72
Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA) Yogita P. Patil, Hilary Shmeeda, Yasmine Amitay, Nanomedicine Nanotechnology Biology and Medicine Drug TargetingPolymer-drug ConjugateFolate-conjugated LiposomesTargeted Drug DeliveryExtracellular Microvesicles	2018	66
Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: Studies with human gastro-entero-pancreatic ectopic tumor models Alberto Gabizón, Yasmine Amitay, Dina Tzemach, Journal of Controlled Release Lipid PreparationDrug TargetingPancreatic CancerMitomycin CMedicine	2011	64
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients Talia Golan, Tal Grenader, Patricia Ohana, Cancer Medicine	2015	55
Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer Hilary Shmeeda, Yasmine Amitay, Jenny Gorin, Journal of drug targeting Pharmaceutical ScienceNanotherapeuticsNanomedicineMedicinal ChemistryMolecular Pharmacology	2016	43
Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues Yasmine Amitay, Hilary Shmeeda, Yogita P. Patil, Pharmaceutical Research Lipid PreparationMedicinal ChemistryPharmaceutical ScienceBiochemistryMitomycin C	2015	36
Characterization of Pegylated Liposomal Mitomycin C Lipid-Based Prodrug (Promitil) by High Sensitivity Differential Scanning Calorimetry and Cryogenic Transmission Electron Microscopy Xiaohui Wei, Yogita P. Patil, Patricia Ohana, Molecular Pharmaceutics Pl-mlp Liposome MembraneLipid AnalysisProteinlipid InteractionLipid PreparationBiochemistry	2017	22

Page 1